p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL

por Lee, H J, Gallardo, M, Ma, H, Zhang, X, Larsson, C A, Mejia, A, Hornbaker, M J, Qi, Y, Su, X, Pageon, L R, Quintas-Cardama, A, Post, S M
Publicado 2016